In this article
Harvard Study Links Bacteria to Colon Cancer Metastasis
Researchers from Harvard University found evidence in a new study that colon cancer cells carry certain bacteria when they metastasize to other organs in the body. The results of the study were published in the journal Science, and the team described their possible association with bacteria and their cause of colon cancer.
Previous research has shown that bacteria and tumor cells are present in various types of cancer, which makes some people in the medical community wonder whether they are the real cause of tumor formation. A bacterium called Fusobacterium nucleatum has been shown to exist in colon cancer cells. In this new study, the researchers wanted to know whether the same bacteria can be found in colon cancer tumor cells when these cancer cells have metastasized to other parts of the body.
To find out, the researchers collected tissue samples from patients with colon cancer. In the course of the research, they found that in many cases, the same bacterial strain exists in the tumor. Even if colon cancer cells have metastasized, the most common metastatic site of colon cancer is the liver, but there is no evidence to show that the bacteria in colon cancer cells , Present in the liver.
Antibiotic Treatment Potential in Mouse Models
The researchers were very interested in this discovery. The researchers implanted tumors in healthy mice, so they found that those tumors with bacteria began to grow. Next, the research team tested the possibility of using antibiotics capable of killing F. nucleatum to treat colon cancer mice. They found that doing so actually slowed the growth of the tumor.
This discovery allows researchers to find a new direction against colon cancer, and hopes that further research can prove the effectiveness and safety of this method.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
About Dr. Nishant Mittal
Dr. Nishant Mittal is a highly accomplished researcher with over 13 years of experience in the fields of cardiovascular biology and cancer research. Significant contributions to stem cell biology, developmental biology, and innovative research techniques mark his career. Research Highlights Dr. Mittal's research has focused on several key areas: 1) Cardio…
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.